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INTRODUCTION  
Oral Submucous Fibrosis (OSMF) is a chronic 
disease affecting the oral mucosa, as well as the 
pharynx and the upper two thirds of the 
esophagus. It is characterized by burning 
sensation in the oral cavity, blanching and 
stiffening of the oral mucosa and oropharynx 
which ultimately leads to trismus.1  
 
Various etiologies have been proposed earlier 
including chillies, nutritional deficiency, 
autoimmunity and genetic susceptibility.2 
Presently, the etiology of OSMF is mainly 
attributed to the use of areca nut and quid 
chewing habit.3 Areca nuts contain alkaloids, of 
which arecoline seems to be a primary etiologic 
factor. Arecoline has the capacity to modulate 
matrix metalloproteinases, lysyl oxidases, and 
collagenases which affects the metabolism of 
collagen leading to an increased fibrosis.4  
 
Steroids have been the mainstay of treatment for 
OSMF.   Steroids    inhibit     the    proliferation   of  
 
 
 
 
 
 
fibroblasts and this causes reduction in the 
number of collagen fibres. They act to release 
cellular proteases in the connective tissue 
extracellular component which in turn activates 
the collagens and zymogen that ingest the 
insoluble collagen stimulating the rate of collagen 
breakdown. But disadvantages of intralesional 
steroids like patient discomfort and fibrosis due to 
needle trauma has led to research on other 
interventions.5 One such intervention is 
physiotherapy which encompasses mouth 
exercises, heat, therapeutic ultrasound and 
microwave diathermy. Physiotherapy is a non 
invasive modality which may aid in the 
symptomatic treatment of patients with OSMF.  
 
The treatment for patients who are unwilling for 
intralesional  injections   can    be     advised   to do 
mouth exercises to increase the mouth opening, 
tongue protrusion and cheek flexibility.  
 
The aim of this study was to assess the efficacy of  
physiotherapy    in    improving    mouth   opening,  
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tongue protrusion and cheek flexibility in patients 
with OSMF.   
  
MATERIALS AND METHODS 
Prior to study, ethical clearance was obtained from 
the institutional review board. The study 
population consisted of 48 OSMF patients aged 
between 16-50 years showing clinical evidence of 
OSMF stage II (according to Pindborg’s 
classification) and with subjective reduction in 
mouth opening less than 35 mm and reduced 
cheek flexibility.  Patients with mouth opening of 
less than 12 mm, patients with reduced mouth 
opening due to temporomandibular disorders or 
third molar impaction and patients diagnosed 
with oral squamous cell carcinoma were excluded 
from the study. 
  
Simple Random sampling technique was used to 
distribute the sample size into three groups 
numbered 1, 2, 3 by picking up paper chits. All the 
patients were also counselled to quit areca nut 
chewing habit and given lycopene 4 mg once a day 
for a month.  A complete haemogram was done for 
all patients and were advised to take a haematinic 
syrup or referred to a physician if found to be 
anemic.   
 
Group 1 patients were treated with Intralesional 
injections of hyaluronidase (1500 U) and 
dexamethasone (4 mg/ml) biweekly for 6 weeks, 
Group 2 patients were treated with basic 
Physiotherapy regimen consisting of mouth 
exercises (Figure 1) twice a day for 6 weeks and 
Group 3 patients were treated with both 
Physiotherapy and Intralesional injections.  
 
 Mouth opening, tongue protrusion and cheek 
flexibility were measured before intervention and 
at intervals of 2 weeks, 4 weeks and 6 weeks after 
treatment. The maximum inter-incisal distance 
using geometric divider and scale was measured as 
the mouth opening. Tongue protrusion was 
measured as the distance between incisal edge of 
maxillary incisors and position of maximum 
tongue protrusion. For cheek flexibility, two 
points were marked on both the cheeks of the 
patients at 1/3rd the distance from the angle of the 
mouth on a line joining the tragus and the angle 
of the mouth. The patients were then asked to 
blow their cheeks fully and distance was measured 
between these two points. This depicted the cheek 
fullness with air. The subjects were then asked to 
blow out the air and relax and distance was 
measured again between the two points. The 
difference between these two values depicted the 
cheek flexibility.6  
 
Statistical Analysis  
Intragroup and intergroup analysis was done 
using Analysis of variance (ANOVA) to assess the 
mean values of mouth opening, tongue protrusion 
and cheek flexibility. The p- value of <0.05 was 
considered as statistically significant.  
  
RESULTS 
A dropout of 3 patients per group was seen with 
the final sample size of 39 patients which was 
analysed statistically.  The parameters of mouth 
opening, tongue protrusion and cheek flexibility 
were assessed within each group at a time interval 
of 2 weeks, 4 weeks and 6 weeks. Also, an 
intergroup analysis was done for the same three 
parameters before initiation of treatment to the 
end of 6 weeks.  
 
Intergroup analysis revealed that mean difference 
in mouth opening before initiation of treatment to 
end of 6 weeks was maximum in Group 3 
[Physiotherapy and injection] (4.80±3.4) followed 
by Group 1 [Injection] (4.0±2.8) and Group 2 
[Physiotherapy] (2.73±1.7). The mean difference 
was also highest for tongue protrusion and cheek 
flexibility in Group 3 with value of 8.30±4.5 and 
0.25±0.2 respectively. The mean difference of 
cheek flexibility in Group 1 was comparable to the 
Group 3 with value of 0.2±0.2 while it was lesser 
when compared to the same for tongue protrusion 
(6.31±2.7).  Group 2 showed least values for tongue 
protrusion (4.92±1.7) and cheek flexibility 
(0.1±0.1). The mean difference of tongue 
protrusion among the three groups was found to 
be statistically significant (p=0.033) (Table 1). 
 
Cheek flexibility was found to be statistically 
significant in Group 3 (p=0.05) when analyzed at 
specific intervals of 2 weeks, 4 weeks and 6 weeks 
while tongue protrusion was statistically 
significant in Group 1 (p=0.048) (Table 2). 
 
DISCUSSION 
Submucous fibrosis of the oral cavity was first 
described by Schwartz in 1952 in five Indian 
females from Kenya and East Africa. Initially the 
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term “atrophia idiopathica mucosae oris” was 
proposed, which was later replaced by the term 
currently being used.7 The prevalence in India 
ranges from 0.2 to 0.5 percent with a higher 
predominance in the southern parts of the 
subcontinent. Individuals between the ages of 20 
& 40 years are most commonly affected but cases 
have been reported in patients ranging from two 
years to eighty nine years of age.8 
 
Multiple treatment approaches for OSMF 
including both medical and surgical interventions 
has been tried.  Since chewing of areca nut have 
been considered as one of the significant etiologies 
in the pathogenesis of OSMF, the primary therapy 
should be cessation of habit. Hence, patients 
should be counselled to quit the habit. The 
patients in this study were advised for oral 
prophylaxis which motivated the patients to not 
indulge in the habit again and also helped us to 
monitor any patients who had continued the 
habit.  
 
Medical therapies like corticosteroids,9 placental 
extracts,10 hyaluronidase,11 pentoxifylline8 etc. 
have been used earlier which has been found to 
have good results. Surgery is indicated in patients 
with severe trismus when other techniques have 
failed to improve the condition. But the results are 
not satisfactory as there is contracture of wound 
healing leading to more fibrosis.12 Intralesional 
corticosteroids  like dexamethasone is the most 
widely used treatment in India and numerous 
studies have proved its efficacy in improving 
mouth opening in OSMF patients.  But it has low 
patient compliance, with many patients failing to 
return for their subsequent follow ups due to 
needle trauma and trypanophobia. Thus 
physiotherapy can be used as an alternate therapy 
to improve mouth opening in such patients with 
OSMF.  
 
Researches using different physiotherapeutic 
modalities have shown to improve restricted 
mouth opening in OSMF patients.13,14  
Physiotherapy has been used in the form of 
forceful mouth opening to jaw opening devices.  
 
Forceful mouth opening has been almost 
discarded owing to the poor results and the fact 
that it may accentuate the fibrosis. Heat has also 
been commonly used and the results have been  
 
described      as       satisfactory.12  
 
Usually, physiotherapy is incorporated post-
surgery to aid in increase in mouth opening with 
the help of jaw opening devices and tongue 
spatulas. It is seldom used as a sole or primary 
treatment modality in improving the symptoms in 
OSMF patients. Physiotherapy has the benefits of 
being a non-invasive technique, being less 
traumatic to the patient and requiring no financial 
sources. Mouth exercises can be performed 
anywhere during the day which adds to its benefit 
as a patient compliant technique.  
 
The present study incorporated a mouth exercise 
regimen15 used in patients suffering from 
dysphagia. To the best of our knowledge this 
regimen has been used for the first time in OSMF 
patients. The efficacy of these mouth exercises in 
treating patients with OSMF was assessed and a 
mean increase in mouth opening, tongue 
protrusion and cheek flexibility was found in 
patients performing mouth exercises. A marked 
increase in all the three parameters was noted in 
the group treated with both intralesional 
injections and physiotherapy. The improvement 
in the physiotherapy group was to a lesser degree 
than the other two groups for all three parameters. 
This may be attributed to negligence on the 
patients’ part to perform the exercises regularly as 
advised. Also, since follow up visits were spaced at 
a time interval of 2 weeks, the patients were 
motivated less to perform the exercises regularly. 
On the other   hand,     patients    receiving   
biweekly    injections and performing 
physiotherapy exercises were regularly reinforced  
to perform the exercises due to which the benefits 
of both physiotherapy and intralesional injections 
were shown in the results.  
  
CONCLUSION 
 In this study, physiotherapy used alone was 
shown to improve the mean mouth opening, 
tongue protrusion and cheek flexibility but was 
not statistically significant. But the simultaneous 
use of physiotherapy and intralesional injections 
was found to improve these parameters better 
than physiotherapy alone. This suggests that use 
of these modalities together with patient 
motivation can aid in better management of the 
signs and symptoms of patients with OSMF. 
Physiotherapy can be used as an adjuvant 
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treatment modality which can potentiate the 
action of other treatments like intralesional 
steroids. As physiotherapy requires less resources 
and is non traumatic, it is more preferred by 
patients. Therefore, physiotherapy should be 
included as an adjunct therapy for treating 
patients with OSMF. It can be also implemented 
as a primary treatment in patients unwilling for 
intralesional steroids. 
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Group No of samples Mouth opening Tongue protrusion Cheek flexibility 
Injection 13 4.0±2.8 6.31±2.7 0.2±0.2 
Physiotherapy  13 2.73±1.7 4.92±1.7 0.1±0.1 
Injection & Physiotherapy 13 4.80±3.4 8.30±4.5 0.25±0.2 
P value  0.163 0.033* 0.304 
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Table 1. Comparison of mean difference (before intervention- 6weeks) [Mean±SD] 
among all the groups. (p < 0.05  - Significant*, p < 0.001 - Highly significant**) 
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Group Mouth opening Tongue protrusion Cheek flexibility 
 Initial 2week
s 
4week
s 
6week
s 
P 
val
ue 
Initial 2week
s 
4week
s 
6week
s 
p 
valu
e 
Initial 2wee
ks 
4wee
ks 
6wee
ks 
P value 
Injection 27.07±
6.1 
28.84±
5.0 
30.30±
4.4 
31.07±
4.9 
0.2
21 
35.92±
5.5 
37.61±
5.6 
40.23±
5.9 
42.23±
6.8 
0.04
8* 
0.76±0.
3 
0.67±
0.2 
0.66±
0.1 
0.6±0
.2 
0.259 
Physiothe
rapy 
28.92±
4.6 
30.07±
5.6 
30.76±
5.8 
31.65±
6.1 
0.6
45 
38.92±
7.1 
41.11±
7.4 
42.88±
7.5 
43.84±
7.4 
0.34
9 
0.75±0.
2 
0.79±
0.3 
0.73±
0.2 
0.65±
0.2 
0.482 
Injection 
& 
Physiothe
rapy 
26.50±
4.3 
29.46±
5.9 
30.88±
5.7 
31.31±
5.9 
0.1
22 
38.23±
6.7 
41.84±
8.1 
44.23±
8.4 
46.53±
8.5 
0.06
5 
0.81±0.
2 
0.68±
0.1 
0.64±
0.1 
0.56±
0.2 
0.05* 
 
 
 
 
 
 
 
 
 
Figure 1.  Mouth exercise regimen advised to the patients in Group 2 and 3 
Table 2. Comparison of mouth opening, tongue protrusion and cheek flexibility (Mean±SD)  at 
different time intervals. (p < 0.05  - Significant*, p < 0.001 - Highly significant**) 
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